Analyst Activity – Credit Suisse Group Lowers Its Price Target On AstraZeneca plc (LON:AZN) to GBX 4,700

ME Staff
-
0

Analyst Ratings For AstraZeneca plc (LON:AZN)

Today, Credit Suisse Group lowered its price target on AstraZeneca plc (LON:AZN) to GBX 4,700 per share.

There are 2 sell ratings, 9 hold ratings, 9 buy ratings on the stock.

The current consensus rating on AstraZeneca plc (LON:AZN) is Hold (Score: 2.35) with a consensus target price of GBX 5,241.37 per share, a potential .

Some recent analyst ratings include

  • 7/28/2017-Deutsche Bank AG Reiterated Rating of Buy.
  • 7/27/2017-Shore Capital Reiterated Rating of Hold.
  • 7/27/2017-Liberum Capital Reiterated Rating of Buy.
  • 7/26/2017-Barclays PLC Reiterated Rating of Overweight.
  • 7/21/2017-J P Morgan Chase & Co Reiterated Rating of Neutral.


    Recent Trading Activity for AstraZeneca plc (LON:AZN)
    Shares of AstraZeneca plc closed the previous trading session at 4,359.50 up +43.40 1.01% with 10,636,810 shares trading hands.